Results 191 to 200 of about 7,668 (229)

Polypoidal choroidal vasculopathy

Ophthalmology Clinics of North America, 2002
Polypoidal choroidal vasculopathy seems to be a distinct clinical entity that should be differentiated from other types of CNV associated with AMD and other known choroidal degenerative, inflammatory, and ischemic disorders. The principle abnormality seen in PCV, notably the branching vascular network and polypoidal structures at the borders of the ...
Antonio P, Ciardella, Irene M, Donsoff, Lawrence A, Yannuzzi   +2 more
openaire   +2 more sources

Clinical explainable differential diagnosis of polypoidal choroidal vasculopathy and age-related macular degeneration using deep learning

Comput. Biol. Medicine, 2022
BACKGROUND This study aims to achieve an automatic differential diagnosis between two types of retinal pathologies with similar pathological features - Polypoidal choroidal vasculopathy (PCV) and wet age-related macular degeneration (AMD) from volumetric
Da Ma, Meenakshi Kumar, V. Khetan, P. Sen, M. Bhende, Shuo Chen, T. Yu, Sieun Lee, E. Navajas, Joanne A. Matsubara, M. Ju, M. Sarunic, R. Raman, M. Beg   +13 more
semanticscholar   +1 more source

TYPICAL POLYPOIDAL CHOROIDAL VASCULOPATHY AND POLYPOIDAL CHOROIDAL NEOVASCULARIZATION

Retina, 2019
Purpose: To compare typical polypoidal choroidal vasculopathy (T-PCV) and polypoidal choroidal neovascularization (P-CNV), which can be defined as two subtypes of PCV, and to elucidate the significance of the classification. Methods: Seventy-seven patients diagnosed with PCV and ...
Jun Won, Jang, Jong Min, Kim, Se Woong, Kang, Sang Jin, Kim, Kunho, Bae, Kyung Tae, Kim   +5 more
openaire   +2 more sources

Polypoidal choroidal vasculopathy and treatments

Current Opinion in Ophthalmology, 2008
This review assesses the current knowledge of the clinical characteristics of polypoidal choroidal vasculopathy and treatments.Polypoidal choroidal vasculopathy is a disease with characteristic choroidal vascular abnormalities. Indocyanine green angiography is essential for diagnosis.
Fumi, Gomi, Yasuo, Tano
openaire   +2 more sources

Photodynamic therapy for polypoidal choroidal vasculopathy

Progress in Retinal and Eye Research, 2013
The first effective therapy for exudative macular degeneration (AMD) was Photodynamic Therapy (PDT). Diagnosis of the disease was to a large extent by fluorescein angiography (FA).
Patrycja Nowak-Sliwinska, Hubert Van Den Bergh   +1 more
exaly   +2 more sources

Polypoidal choroidal vasculopathy with drusen

Japanese Journal of Ophthalmology, 2008
To study the prevalence and clinical features of drusen in eyes with polypoidal choroidal vasculopathy (PCV).Retrospectively, we reviewed the records of 98 consecutive patients with PCV (102 eyes). Drusen were examined in the inner macula, which was defined as an area within 1500 microm of the center of the fovea.
Daisuke, Iwama, Akitaka, Tsujikawa, Manabu, Sasahara, Yasuhiko, Hirami, Hiroshi, Tamura, Nagahisa, Yoshimura   +5 more
openaire   +2 more sources

Analysis of the aqueous humor lipid profile in patients with polypoidal choroidal vasculopathy.

Experimental Eye Research, 2022
This study aimed to investigate the lipid profiles of aqueous humor from polypoidal choroidal vasculopathy (PCV) patients and identify potential biomarkers to increase the understanding of PCV pathomechanism.
Bing Liu, Chenyang Cong, Zhongen Li, Linlin Hao, Xiaomeng Yuan, Wenqi Wang, Yanmei Shi, Tingting Liu   +7 more
semanticscholar   +1 more source

POLYPOIDAL CHOROIDAL VASCULOPATHY IN ITALY

Retina, 2001
To report on the frequency and clinical features of polypoidal choroidal vasculopathy (PCV) in a consecutive series of elderly Italian patients presenting with macular exudation.The authors conducted a retrospective study on a series of 194 consecutive patients 50 years or older with newly diagnosed exudative maculopathy and the presumed diagnosis of ...
B, Scassellati-Sforzolini, C, Mariotti, R, Bryan, L A, Yannuzzi, M, Giuliani, A, Giovannini   +5 more
openaire   +2 more sources

Comparison of visual outcomes of polypoidal choroidal vasculopathy and typical neovascular age‐related macular degeneration—up to 10 years of follow‐up

Acta ophthalmologica, 2022
To investigate long‐term visual outcomes of patients with polypoidal choroidal vasculopathy (PCV) and typical neovascular age‐related macular degeneration (nAMD) in the real‐world setting.
Jun Young Park, Young Joo Park, S. Park, K. Park, J. Yeo, June‐G. Kim, Y. Yoon, J. Lee, S. Woo   +8 more
semanticscholar   +1 more source

Polypoidal Choroidal Vasculopathy: A Review

Survey of Ophthalmology, 2010
More than a quarter century has passed since the original description of polypoidal choroidal vasculopathy (PCV) in 1982 as a peculiar hemorrhagic disorder involving the macula characterized by recurrent subretinal pigment epithelial bleeding. In the ensuing years, numerous reports have described the expanded clinical spectrum of this entity.
Yutaka, Imamura, Michael, Engelbert, Tomohiro, Iida, K Bailey, Freund, Lawrence A, Yannuzzi   +4 more
openaire   +2 more sources